VHCP Management as of Sept. 30, 2014
Portfolio Holdings for VHCP Management
VHCP Management holds 18 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Avalanche Biotechnologies In | 18.8 | $42M | 1.4M | 30.16 | |
| Anacor Pharmaceuticals In | 13.0 | $29M | 1.2M | 24.47 | |
| Dbv Technologies (DBVTF) | 11.9 | $26M | 565k | 46.61 | |
| Gw Pharmaceuticals Plc ads | 11.4 | $25M | 312k | 80.85 | |
| Dyax | 9.2 | $20M | 2.0M | 10.12 | |
| BioCryst Pharmaceuticals (BCRX) | 7.7 | $17M | 1.7M | 9.78 | |
| Radius Health | 5.0 | $11M | 525k | 21.00 | |
| Zafgen | 4.5 | $10M | 542k | 18.51 | |
| Heron Therapeutics (HRTX) | 4.1 | $9.1M | 1.1M | 8.33 | |
| Flamel Technologies | 3.2 | $7.2M | 500k | 14.31 | |
| Neurocrine Biosciences (NBIX) | 2.1 | $4.8M | 304k | 15.67 | |
| Lipocine | 1.9 | $4.1M | 670k | 6.11 | |
| Therapeuticsmd | 1.8 | $3.9M | 847k | 4.64 | |
| Zs Pharma | 1.8 | $3.9M | 100k | 39.23 | |
| Ohr Pharmaceutical | 1.6 | $3.5M | 477k | 7.25 | |
| Ocera Therapeutics | 1.6 | $3.4M | 704k | 4.90 | |
| D Stemline Therapeutics | 0.4 | $883k | 71k | 12.44 | |
| Alexza Pharmaceuticals | 0.1 | $166k | 71k | 2.33 |
